AI-generated price forecast for Beam Therapeutics (BEAM) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.
As of October 2026: K3vl4r's AI model currently reads BEAM as 2/2 bullish · strong across its horizons (2 of 2 timeframes pointing up), with a last price of 24.45. Measured over its last 36 resolved weekly forecasts (60-day window), the model's direction call on BEAM was correct 69% of the time. See our public, auditable track record →
Last price
24.45
AI outlook
2/2 bullish · STRONG
Timeframes up
2 / 2
Measured weekly accuracy
69%
36 resolved forecasts · 60d window
| Horizon | Direction | Projected move (end of horizon) | Bullish prob. |
|---|---|---|---|
| 1-hour | — | — | — |
| 4-hour | — | — | — |
| Daily~3 months out | ▲ Up | +1.84% | 100% |
| Weekly~1.8 years out | ▲ Up | +38.53% | — |
From the market-news feed the forecasts are read against.
🔒
See the full BEAM forecast
Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.
Create a free account →Already have one? Log in
K3vl4r's AI model currently reads BEAM as 2/2 bullish · STRONG — 2 of 2 forecast horizons point up, so the overall read is leaning to the upside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Measured over its last 36 resolved weekly forecasts (60-day window), the model's direction call on BEAM was correct 69% of the time. Accuracy is recomputed continuously against resolved outcomes and varies by symbol, horizon and market regime; past accuracy does not guarantee future results. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
K3vl4r's model projects BEAM toward $24.52 over the next ~3 months, a +0.0% move from $24.52. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Over its longest horizon (~~1.8 years), the model's projected target for BEAM is $24.54 (+0.4% vs $24.45). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.
Part of Biotech & Pharma forecasts — browse the full sector.
Or see the full BEAM price prediction (2027–2040), or the forecast for today, tomorrow and this week.
Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.
K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.
Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.